Global edition
Region
NewsWebcastsPodcastsThe Magazine
Sign inSubscribe
Follow Pharma Now@pharmanow.live
Editions & local coverage
United StatesUnited KingdomGermanyFranceItalyIndiaSwitzerlandSingapore

A global knowledge and leadership platform for pharma. We turn complexity into clarity professionals can act on.

Get the Pharma Now app

Read offline, save stories and never miss an edition.

Get it onGoogle PlayDownload on theApp Store
Verticals
  • Microbiology & CCS
  • Pharma IT
  • Pharma Marketing
  • Regulatory Intelligence
  • Bio Pharma
  • Future Pharma Trends
Formats
  • News & Analysis
  • Interviews
  • Webcasts
  • Podcasts
  • Events
  • Magazine
Knowledge Hub
  • Knowledge Hub
  • Research Papers
  • Buyer’s Guides
  • Companies
  • Newsletter Archive
  • Glossary
Company
  • Advisory Board
  • Contributors
  • Write for Us
  • Submit a PR
  • Contact
  • Advertise
Account
  • Subscribe
  • Sign in
  • My Account
Frequently asked

Pharma Now is a leading monthly B2B magazine focused on delivering in-depth content related to the pharmaceutical and biopharma sectors. It covers the latest trends, technological innovations, leadership insights, market developments, and interviews with industry experts.

Pharma Now provides comprehensive coverage, including: - Industry news and updates - Interviews with global pharma leaders - Market insights and trends - Innovations in AI, manufacturing, and pharma operations - Case studies, thought leadership articles, and regulatory updates

Pharma Now caters to a wide range of professionals within the pharmaceutical industry, including C-level executives, R&D professionals, quality managers, regulatory affairs specialists, and business leaders looking to stay informed about global trends and innovations.

You can subscribe to Pharma Now by visiting the Pharma Now website and choosing between print and digital editions.

Yes, Pharma Now welcomes contributions from industry experts. Contributors can submit articles, thought leadership pieces, and case studies. You can register on the contributors' page to submit content and gain recognition for your insights.

Pharma Now offers multiple advertising packages tailored to help companies promote their products, services, and innovations. From full-page ads to special event coverage, advertisers can reach a targeted audience of pharma professionals. For details, visit the Advertise With Us section on the website.

Copyright © 2026 Tantragyan Technologies Pvt Ltd. All Rights Reserved.
Privacy PolicyTerms of UseContact UsAdvertise
Advisory Board>Abdulaziz A. AlSayyari, Ph.D. MBA

Abdulaziz A. AlSayyari, Ph.D. MBA

Former Executive Director

Abdulaziz A. AlSayyari, Ph.D. MBA

Bio

​Abdulaziz A. AlSayyari is a distinguished professional with extensive experience in the pharmaceutical and regulatory sectors. He has held pivotal roles such as Executive Director of Quality Evaluation for Medicinal Products and Director of the Evaluation of Biological Medicine at the Saudi Food and Drug Authority (SFDA), where he played a crucial part in ensuring the safety and efficacy of medicinal products in Saudi Arabia. His expertise in quality evaluation and biological medicine has significantly contributed to the advancement of healthcare standards in the region.

In addition to his regulatory accomplishments, Dr. AlSayyari has demonstrated a commitment to continuous professional development. He recently completed the Senior Executive Program at London Business School, an intensive four-week course that broadened his strategic leadership skills. Further enhancing his business acumen, he earned an Executive MBA focused on Innovation and Business Development from IMD Business School. These academic pursuits underscore his dedication to integrating innovative strategies within the pharmaceutical industry, aiming to improve healthcare delivery and patient outcomes.

Education

Master of Business Administration (MBA), Business Administration and Management

IMD Business School (Nov 2023 – Feb 2025)

Senior Executive Program 107, Business Administration, Management and Operations

London Business School (Nov 2022)

Doctor of Philosophy (PhD), Bioprocess Engineering

Wageningen University & Research (2013)

Biotechnology

University of Nottingham (2009)

Medical Biotechnology

Winston-Salem State University (2004)

Professional Background

Executive Director of Quality Evaluation for Medicinal Products

Saudi Food and Drug Authority (SFDA) (Aug 2021 – Jan 2024)

Director, The Evaluation of Biological Medicine

Saudi Food and Drug Authority (SFDA) (Aug 2018 – Aug 2021)

Biotechnology and Biosimilars Products Reviewer

Saudi Food and Drug Authority (SFDA) (Nov 2017 – Aug 2021)

Biosimilar Products Reviewer

Saudi Food and Drug Authority (SFDA) (2008 – 2013)

Expertise

Regulatory Compliance

Join our Advisory Board

Be a part of world’s largest pharma community

Advisory Board
Pharma Now

Weekly Pharma insights directly in your inbox

Get most important news delivered to your email inbox